ATE510906T1 - Kv10.1, ein neuer potential-abhängiger kaliumkanal des menschlichen gehirns - Google Patents

Kv10.1, ein neuer potential-abhängiger kaliumkanal des menschlichen gehirns

Info

Publication number
ATE510906T1
ATE510906T1 AT01926989T AT01926989T ATE510906T1 AT E510906 T1 ATE510906 T1 AT E510906T1 AT 01926989 T AT01926989 T AT 01926989T AT 01926989 T AT01926989 T AT 01926989T AT E510906 T1 ATE510906 T1 AT E510906T1
Authority
AT
Austria
Prior art keywords
potassium channel
human brain
new potential
dependent potassium
members
Prior art date
Application number
AT01926989T
Other languages
English (en)
Inventor
Timothy Jegla
Original Assignee
Icagen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icagen Inc filed Critical Icagen Inc
Application granted granted Critical
Publication of ATE510906T1 publication Critical patent/ATE510906T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT01926989T 2000-04-14 2001-04-13 Kv10.1, ein neuer potential-abhängiger kaliumkanal des menschlichen gehirns ATE510906T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19779300P 2000-04-14 2000-04-14
US09/833,466 US6727353B2 (en) 2000-04-14 2001-04-11 Nucleic acid encoding Kv10.1, a voltage-gated potassium channel from human brain
PCT/US2001/012185 WO2001079455A1 (en) 2000-04-14 2001-04-13 Kv10.1, A NOVEL VOLTAGE-GATED POTASSIUM CHANNEL FROM HUMAN BRAIN

Publications (1)

Publication Number Publication Date
ATE510906T1 true ATE510906T1 (de) 2011-06-15

Family

ID=26893173

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01926989T ATE510906T1 (de) 2000-04-14 2001-04-13 Kv10.1, ein neuer potential-abhängiger kaliumkanal des menschlichen gehirns

Country Status (7)

Country Link
US (2) US6727353B2 (de)
EP (1) EP1183330B1 (de)
JP (1) JP2003530849A (de)
AT (1) ATE510906T1 (de)
AU (1) AU780103B2 (de)
CA (1) CA2370572A1 (de)
WO (1) WO2001079455A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2417642A1 (en) * 2000-07-28 2002-02-07 Lexicon Genetics Incorporated Novel human ion channel proteins and polynucleotides encoding the same
CA2427741A1 (en) * 2000-11-02 2002-08-22 Bristol Myers Squibb Company Polynucleotide encoding a novel human potassium channel alpha-subunit, k+alpham1, and variants thereof
WO2002055556A2 (en) * 2001-01-12 2002-07-18 Bayer Ag Regulation of human voltage gated potassium channel protein kv2.2
US7027418B2 (en) 2001-01-25 2006-04-11 Bandspeed, Inc. Approach for selecting communications channels based on performance
US7033790B2 (en) 2001-04-03 2006-04-25 Curagen Corporation Proteins and nucleic acids encoding same
GEP20105110B (en) * 2004-08-03 2010-11-10 Transtech Pharma Inc Rage fusion proteins and their use
US8447252B2 (en) * 2009-01-21 2013-05-21 Bandspeed, Inc. Adaptive channel scanning for detection and classification of RF signals
US8849213B2 (en) * 2009-01-21 2014-09-30 Bandspeed, Inc. Integrated circuit for signal analysis
AU2022275948A1 (en) * 2021-05-20 2023-12-21 Artema Therapeutics, Inc. Kcnv2 variants and their use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710019A (en) * 1995-06-05 1998-01-20 Human Genome Sciences, Inc. Human potassium channel 1 and 2 proteins
JPH09121865A (ja) * 1995-10-30 1997-05-13 Takeda Chem Ind Ltd 新規ｇ蛋白質共役型レセプター蛋白質、その製造法および用途
DE69631540T2 (de) * 1995-11-23 2005-01-27 Cancer Research Technology Ltd. Materialien und methoden mit bezug zur identifizierung und sequenzierung des krebs-suszeptilitaetsgens brca2 und dessen anwendungen
US5856155A (en) 1996-02-23 1999-01-05 The Johns Hopkins University School Of Medicine Compounds and related methods for modulating potassium ion channels and assays for such compounds
AU4758997A (en) 1996-10-17 1998-05-11 Nps Pharmaceuticals, Inc. Potassium channel blocking compounds and their use
WO1999032623A1 (en) * 1997-12-19 1999-07-01 Pharmacia & Upjohn Company Human sel-10 polypeptides and polynucleotides that encode them
US6207811B1 (en) * 1998-03-18 2001-03-27 Karl Tryggvason Nephrin gene and protein
EP1105479B1 (de) * 1998-08-11 2011-01-12 Darwin Discovery Limited Identifikation des gens das zum schorfigen phenotyp der maus führt, sowie seines menschlichen orthologs

Also Published As

Publication number Publication date
WO2001079455A1 (en) 2001-10-25
AU780103B2 (en) 2005-03-03
EP1183330A1 (de) 2002-03-06
WO2001079455A9 (en) 2010-10-07
US20040157261A1 (en) 2004-08-12
EP1183330A4 (de) 2003-06-11
AU5348601A (en) 2001-10-30
US6727353B2 (en) 2004-04-27
EP1183330B1 (de) 2011-05-25
JP2003530849A (ja) 2003-10-21
CA2370572A1 (en) 2001-10-25
US7528231B2 (en) 2009-05-05
US20040053357A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
DE60334460D1 (de) Antikörper spezifisch für das tau-protein des zentralen nervensystems
TR200003036T2 (tr) 12,13-Modifiye edilmiş epotilon türevleri
ATE419388T1 (de) Nukleinsäureanreicherung
EA200300464A1 (ru) ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ
DK1187591T3 (da) IBD-associerede mikrobielle antigener og fremgangsmåder til at anvende samme
BR0009206A (pt) Isolamento e análise de proteina
ATE335481T1 (de) Zolpidem hemitartrat solvat
DE60126337D1 (de) Verfahren zum screenen für gpr40-liganden
ATE510906T1 (de) Kv10.1, ein neuer potential-abhängiger kaliumkanal des menschlichen gehirns
EA199800844A1 (ru) Способ получения r-альфа-пропил-пиперониламина и его аналогов, промежуточные продукты, используемые в этом способе
WO2004046293A3 (en) Amphoteric fluorescent whitening agents
ATE316577T1 (de) Das goodpasture-antigen bindende protein
ATE408631T1 (de) Chimäres protein welches eine intramolekulare chaperon-ähnliche sequenz enthält und dessen anwendung zur insulinproduktion
WO2002026929A3 (en) Kini-3 motor protein and methods for its use
ATE533779T1 (de) Isoliertes photoprotein mtclytin, sowie dessen verwendung
EP1179004A4 (de) Der kalium kanal kcnq5
BR0316544A (pt) Compostos calcilìticos
DE50308032D1 (de) Isoliertes fluoreszierendes protein aus clytia gregaria cgfp, sowie dessen verwendung
ATE376058T1 (de) Kv6.2, eine potential-abhängige untereinheit des kaliumkanals.
WO2001096593A3 (en) Novel motor proteins and methods for their use
WO2002012541A3 (en) Novel motor proteins and methods for their use
WO2003070746A3 (en) Purification and characterization of a prothrombin activator from the bristled of lonomia obliqua
DE60325737D1 (de) Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen
WO2002040649A8 (en) Slo2 and slo4, novel potassium channel proteins from human brain
WO2002079479A3 (en) Motor proteins and methods for their use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties